<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="an increasing number of patients with pneumonia due to the" exact="infection" post="with an unknown virus. The virus, first named 2019"/>
 <result pre="efficacy of remdesivir on hospitalized patients with severe COVID-195. The" exact="treatment" post="was designed as 200 mg of remdesivir on day"/>
 <result pre="and labyrinth disorders, cardiac disorders, etc.8, therefore precautions and further" exact="testing" post="are needed for the safe and effective treatment in"/>
 <result pre="and further testing are needed for the safe and effective" exact="treatment" post="in COVID-19 patients. 4. Abidol Abidol is a broad-spectrum"/>
 <result pre="unknown. Therefore, a clinical trial to use lopinavir/ritonavir for COVID-19" exact="treatment" post="will be launched soon in a hospital in Wuhan,"/>
 <result pre="combination of darunavir and ritonavir could also be a potential" exact="treatment" post="of COVID-19, especially since darunavir has been approved in"/>
 <result pre="mouse immune system to rapidly develop innovative antibodies for the" exact="treatment" post="of virus sepsis. This strategy has shown positive results"/>
 <result pre="more than 4 such projects have been approved for the" exact="treatment" post="of COVID-19 in China, and another one has applied"/>
 <result pre="(FDA) for emergency approval16. 10. Others Other clinical trials of" exact="treatment" post="options are also on the agenda. A search with"/>
 <result pre="remdesivir appears to be the most promising drug for the" exact="treatment" post="of pneumonia caused by COVID-19 pneumonia. Many other agents"/>
 <result pre="Many other agents or strategies are being tested for the" exact="treatment" post="of patients with COVID-19. However, double-blind, randomized controlled trials"/>
 <result pre="POINTS â—Š The recent COVID-19 disease is due to the" exact="infection" post="with the new coronavirus, SARS-CoV-2, causing a pandemic and"/>
 <result pre="Identifier: NCT04257656https://clinicaltrials.gov/ct2/show/NCT04257656 7Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread.69VincentMartin JBergeronEricBenjannetSuzanneEricksonBobbie RRollinPierre EKsiazekThomas GSeidahNabil GNicholStuart TVirology journal2200516115318"/>
 <result pre="of Medicinehttps://clinicaltrials.gov/ 11A Systematic Review of therapeutic agents for the" exact="treatment" post="of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).918MomattinHishamAl-AliAnfal YAl-TawfiqJaffar"/>
 <result pre="Syndrome Coronavirus (MERS-CoV).918MomattinHishamAl-AliAnfal YAl-TawfiqJaffar ATravel medicine and infectious disease30201931252170 12Plasma" exact="treatment" post="of more than 10 people with new coronary pneumonia"/>
 <result pre="February 5, 2020.2020 14Beijing's first new crown pneumonia monoclonal antibody" exact="treatment" post="drug approved for clinical trials.Antibody Circle, February 14, 2020.2020http://www.staidson.com/article/146.html"/>
 <result pre="14, 2020.2020 16Four projects have been approved for stem cell" exact="treatment" post="of severe neocoronavirus pneumonia, and 1 has applied for"/>
</results>
